However, considering the unaltered mTOR activation level (Fig. 3B) and prevention of the HFD-induced insulin resistance by reducing gluconeogenesis (Fig. 7), we believe that the effect of changes in protein level is not likely the primary contributor to the changes in insulin sensitivity in this study. The gene discussed is MTOR; the disease is Insulin resistance.